18.10.2016
Drägerwerk AG & Co. KGaA DE0005550602
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger sees slight decline in net sales in third quarter with EBIT up significantly year on year
Drägerwerk AG & Co. KGaA / Key word(s): 9-month figures
18.10.2016 15:32
Disclosure of an inside information according to Article 17 MAR,
transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Dräger with slight decline in net sales in third
quarter with EBIT up significantly year on year
Based on preliminary figures for the third quarter, Dräger recorded a year-
on-year decline in order intake of 1.7 percent (net of currency effects)
(nominal: -2.7 percent). Net sales decreased by 1.1 percent (net of
currency effects) to EUR 592.9 million (nominal: -1.8 percent). The gross
margin stood at approximately 44.0 percent (Q3 2015: 41.8 percent). EBIT
for the quarter stood at EUR 22.5 million, up significantly on the prior
year (Q3 2015: EUR -22.6 million). However, one-off effects, such as write-
downs on receivables and inventories, in addition to provisions, had a
negative impact of roughly EUR 20 million on the third-quarter result for
2015.
Net of currency effects, this resulted in a year-on-year decline in order
intake of 0.3 percent (nominal: -2.4 percent) and a drop in net sales by
2.6 percent (nominal: -4.4 percent) for the first nine months. The gross
margin stood at approximately 43.9 percent (9 months 2015: 44.5 percent).
Compared to the prior-year period, functional costs decreased by 7.5
percent (net of currency effects) in the first nine months of 2016
(nominal: -8.5 percent). Total EBIT stood at approximately EUR 28.1 million
(9 months 2015: EUR 0.2 million). The EBIT margin rose from 0.0 percent in
the prior-year period to 1.6 percent after nine months.
Business performance remained sluggish overall. In particular, the demand
situation in the Middle East and in many European countries did not improve
significantly during the third quarter. Business in Germany and the
Americas region developed positively.
For fiscal year 2016, Dräger continues to expect net sales growth of
between 0.0 and 3.0 percent (net of currency effects) and an EBIT margin of
between 3.5 and 5.5 percent. Net sales growth will probably be at the lower
end of the forecast range due to the restrained development seen to date.
Dräger will publish its full results for the first nine months of the
fiscal year on November 3, 2016.
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com
Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
[email protected]
Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
[email protected]
Disclaimer
This ad hoc report contains statements on the future development of Dräger
Group. These forward-looking statements are based on the current
expectations, presumptions, and forecasts of the Executive Board as well as
the information available to date. They were compiled to the best of the
company's knowledge. Dräger does not provide any warranty nor assume any
responsibility for the future developments and results described above.
These are dependent on a number of factors. They entail various risks and
contingencies outside of the company's influence and are based on
assumptions which could prove to be incorrect. Dräger does not assume any
responsibility for updating the forward-looking statements contained in
this report. This does not infringe any legal stipulations on the
adjustment of forecasts. Please go to Investor Relations / Financial
Calendar at www.draeger.com for information on all important financial
dates.
18.10.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555
067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
Standard), Hamburg, Hanover, Munich; Regulated Unofficial
Market in Stuttgart, Tradegate Exchange
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Drägerwerk AG & Co. KGaA ISIN: DE0005550602 können Sie bei EQS abrufen
Medtech , 555060 , DRW8 , XETR:DRW8